Literature DB >> 18313142

Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Adrian K West1, Juan Hidalgo, Donnie Eddins, Edward D Levin, Michael Aschner.   

Abstract

Metallothionein (MT) is an enigmatic protein, and its physiological role remains a matter of intense study and debate 50 years after its discovery. This is particularly true of its function in the central nervous system (CNS), where the challenge remains to link its known biochemical properties of metal binding and free radical scavenging to the intricate workings of brain. In this compilation of four reports, first delivered at the 11th International Neurotoxicology Association (INA-11) Meeting, June 2007, the authors present the work of their laboratories, each of which gives an important insight into the actions of MT in the brain. What emerges is that MT has the potential to contribute to a variety of processes, including neuroprotection, regeneration, and even cognitive functions. In this article, the properties and CNS expression of MT are briefly reviewed before Dr Hidalgo describes his pioneering work using transgenic models of MT expression to demonstrate how this protein plays a major role in the defence of the CNS against neurodegenerative disorders and other CNS injuries. His group's work leads to two further questions, what are the mechanisms at the cellular level by which MT acts, and does this protein influence higher order issues of architecture and cognition? These topics are addressed in the second and third sections of this review by Dr West, and Dr Levin and Dr Eddins, respectively. Finally, Dr Aschner examines the ability of MT to protect against a specific toxicant, methylmercury, in the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313142      PMCID: PMC2486367          DOI: 10.1016/j.neuro.2007.12.006

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  180 in total

1.  Neuron death and glial response in pontosubicular necrosis. The role of the growth inhibition factor.

Authors:  H Isumi; Y Uchida; T Hayashi; S Furukawa; S Takashima
Journal:  Clin Neuropathol       Date:  2000 Mar-Apr       Impact factor: 1.368

2.  Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains.

Authors:  J Carrasco; M Giralt; A Molinero; M Penkowa; T Moos; J Hidalgo
Journal:  J Neurotrauma       Date:  1999-11       Impact factor: 5.269

Review 3.  Metallothioneins: new functional and structural insights.

Authors:  M Vasák; D W Hasler
Journal:  Curr Opin Chem Biol       Date:  2000-04       Impact factor: 8.822

4.  Metallothionein-III prevents glutamate and nitric oxide neurotoxicity in primary cultures of cerebellar neurons.

Authors:  C Montoliu; P Monfort; J Carrasco; O Palacios; M Capdevila; J Hidalgo; V Felipo
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

5.  Astrocytes provide cysteine to neurons by releasing glutathione.

Authors:  X F Wang; M S Cynader
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

6.  Evidence for a protective role of metallothionein-1 in focal cerebral ischemia.

Authors:  M van Lookeren Campagne; H Thibodeaux; N van Bruggen; B Cairns; R Gerlai; J T Palmer; S P Williams; D G Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

7.  Metallothioneins are upregulated in symptomatic mice with astrocyte-targeted expression of tumor necrosis factor-alpha.

Authors:  J Carrasco; M Giralt; M Penkowa; A K Stalder; I L Campbell; J Hidalgo
Journal:  Exp Neurol       Date:  2000-05       Impact factor: 5.330

8.  Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion.

Authors:  M van Lookeren Campagne; H Thibodeaux; N van Bruggen; B Cairns; D G Lowe
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

9.  Differential expression of metallothioneins in human prion diseases.

Authors:  T Kawashima; K Doh-ura; M Torisu; Y Uchida; A Furuta; T Iwaki
Journal:  Dement Geriatr Cogn Disord       Date:  2000 Sep-Oct       Impact factor: 2.959

10.  Regulation of metallothionein gene expression by oxidative stress and metal ions.

Authors:  G K Andrews
Journal:  Biochem Pharmacol       Date:  2000-01-01       Impact factor: 5.858

View more
  62 in total

1.  Upregulation of metallothioneins after exposure of cultured primary astrocytes to silver nanoparticles.

Authors:  Eva M Luther; Maike M Schmidt; Joerg Diendorf; Matthias Epple; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-04-05       Impact factor: 3.996

2.  Characterization of the role of metallothionein-3 in an animal model of Alzheimer's disease.

Authors:  Yasmina Manso; Javier Carrasco; Gemma Comes; Gabriele Meloni; Paul A Adlard; Ashley I Bush; Milan Vašák; Juan Hidalgo
Journal:  Cell Mol Life Sci       Date:  2012-06-22       Impact factor: 9.261

Review 3.  Zinc-permeable ion channels: effects on intracellular zinc dynamics and potential physiological/pathophysiological significance.

Authors:  Koichi Inoue; Zaven O'Bryant; Zhi-Gang Xiong
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

Review 4.  Mechanisms of neurovascular dysfunction in acute ischemic brain.

Authors:  Y Terasaki; Y Liu; K Hayakawa; L D Pham; E H Lo; X Ji; K Arai
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 5.  Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Authors:  Aracely Garcia-Garcia; Laura Zavala-Flores; Humberto Rodriguez-Rocha; Rodrigo Franco
Journal:  Antioxid Redox Signal       Date:  2012-05-03       Impact factor: 8.401

6.  Regulation of Intracellular Copper by Induction of Endogenous Metallothioneins Improves the Disease Course in a Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Eiichi Tokuda; Shunsuke Watanabe; Eriko Okawa; Shin-ichi Ono
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 7.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

8.  Zinc promotes the death of hypoxic astrocytes by upregulating hypoxia-induced hypoxia-inducible factor-1alpha expression via poly(ADP-ribose) polymerase-1.

Authors:  Rong Pan; Chen Chen; Wen-Lan Liu; Ke-Jian Liu
Journal:  CNS Neurosci Ther       Date:  2013-04-13       Impact factor: 5.243

Review 9.  Roles of zinc and metallothionein-3 in oxidative stress-induced lysosomal dysfunction, cell death, and autophagy in neurons and astrocytes.

Authors:  Sook-Jeong Lee; Jae-Young Koh
Journal:  Mol Brain       Date:  2010-10-26       Impact factor: 4.041

10.  Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats.

Authors:  Gouda K Helal; Abdulaziz M Aleisa; Omayma K Helal; Salim S Al-Rejaie; Abdulaziz A Al-Yahya; Abdulhakeem A Al-Majed; Othman A Al-Shabanah
Journal:  Oxid Med Cell Longev       Date:  2009 Jan-Mar       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.